Weigang Zhao

Weigang Zhao

Auto-generated profile, based on publicly available information

Weigang Zhao

Shanghai Sixth Peoples Hospital

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2020 in World Journal of Emergency Surgery
Verified
Journal Article
Open access
PDF file
WZWeigang Zhao
Weigang Zhao
YCYonglin Chen
Yonglin Chen
WHWeiwei He
Weiwei He
YZYonghong Zhao
Yonghong Zhao
YYYi Yang
Yi Yang
Background: Nonintubated video-assisted thoracoscopic surgery has been widely reported in the past decade, while nonintubated chest wall stabilization has not been reported previously. The aim of this study was to evaluate the safety and feasibility of nonintubated minimally invasive chest wall stabilization in patients with multiple rib fractures. Methods: We conducted a prospective, single-arm, observational study. In this prospective study, 20 consecutive patients with multiple rib fractures were treated using nonintubated minimally invasive chest wall stabilization. Results: Minimally invasive chest wall stabilization was mostly performed for lateral rib fractures in this study (n = 8). The mean operation time was 92.5 min, and the mean blood loss was 49 ml. No patient required conversion to tracheal intubation. The mean extubation time of the laryngeal mask was 8.9 min; the mean postoperative fasting time was 6.1 h; the mean postoperative hospital stay was 6.2 days; the mean amount of postoperative drainage was 97.5 ml; the mean postoperative pain score was 2.9 points at 6 h, 2.8 points at 12 h, and 3.0 points at 24 h; and the mean postoperative nausea and vomiting score was 1.9 points at 6 h, 1.8 points at 12 h, and 1.7 points at 24 h. Conclusions: Nonintubated minimally invasive chest wall stabilization is safe and feasible in carefully selected patients. Further studies with a large sample size are warranted. Trial registration: ChiCTR1900025698. Registered on 5 September 2019.

18 November 2021 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
ZSZuodong Song
Zuodong Song
SZShu Zhu
Shu Zhu
TCTangbing Chen
Tangbing Chen
WZWeigang Zhao
Weigang Zhao
Background: Thymic tumors usually present with adjacent organ invasion or pleural dissemination, but very few studies have reported on occult pleural dissemination detected intraoperatively. This study aimed to investigate the risk factors that can predict pleural dissemination preoperatively. Methods: Consecutive patients with thymic tumors who underwent surgery from January 2010 to January 2017 were reviewed. Only patients without pleural dissemination detected preoperatively were included in this study. Demographic, clinical, pathological, and survival data were collected for statistical analysis. Further analyses were performed to find the risk factors of occult pleural dissemination. Results: A total of 352 patients with thymic tumors were included in this study. Seven patients had pleural dissemination detected intraoperatively. All pleural dissemination cases were in clinical Masaoka-Koga stage III, and most underwent the video-assisted thoracoscopic surgery (VATS) approach (or VATS exploration). Univariate analysis showed that positive squamous cell carcinoma (SCC) antigen was the only predictor of pleural dissemination (p = 0.009). Tiny nodules close to the diaphragm were detected in the computed tomography scans of 1 case after reviewing the imaging data. Tumor recurrence occurred in 5 patients during follow-up. The disease-free survival rates were better in patients with a solitary nodule than those with multiple nodules (p = 0.019). No significant difference was detected in terms of disease-free survival rates between SCC antigen positive and SCC antigen negative patients. Conclusions: Positive SCC antigen was the only detected risk factor for predicting pleural dissemination in thymic tumors preoperatively in this study. The VATS approach (including VATS exploration) is suggested for patients with clinical Masaoka-Koga stage III and SCC antigen positive thymic tumors, according to our experience.

1 January 2021 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
WZWeigang Zhao
Weigang Zhao
TCTangbing Chen
Tangbing Chen
CJChunyu Ji
Chunyu Ji
LXLiwen Xiong
Liwen Xiong
RLRong Li
Rong Li
WFWentao Fang
Wentao Fang

2 June 2020 in Research Square
Verified
Preprint
Open access
PDF file
WZWeigang Zhao
Weigang Zhao
TCTangbing Chen
Tangbing Chen
YYYi Yang
Yi Yang
Background: No consensus was reached on the surgical procedure for patients with stage I non-small-cell lung cancer(NSCLC) ≤ 2 cm. The aim of this study isto investigate the appropriate surgical procedure forstage I NSCLC≤ 2 cm.Methods: Patients with stage I NSCLC ≤ 2 cm received wedge resection, segmentectomy, lobectomy between January 2004 andDecember 2015 were identified using the Surveillance, Epidemiology, and End Results(SEER) database. Data were stratified by age, gender, race, side, location, grade,histology, extent of lymphadenectomy. Overall survival (OS) and lung cancer-specific survival (LCSS) were compared among patients received wedge resection, segmentectomy, lobectomy. Univariate analysis and multivariable Cox regression were performed to identify the prognostic factors ofOS and LCSS. Results:A total of 16511 patients with stage I NSCLC ≤ 2 cm were included in this study, of whom 2945 patients were classified as stage I NSCLC ≤ 1cm.Lobectomy had better OS and LCSS when compared with wedge resection in patients with NSCLC ≤ 2 cm. Only OS favored lobectomy compared with segmentectomy in stage I NSCLC>1 to 2 cm. Multivariable analysis showed thatsegmentectomy had similar OS and LCSScompared with lobectomy in patients with stage I NSCLC ≤ 2 cm. Lymph node dissection (LND) was associated with better OS in patients with NSCLC≤ 2 cm and better LCSS in patients with stage I NSCLC>1 to 2 cm.Conclusions:Segmentectomy showed comparable survival compared with lobectomy in patients with stage I NSCLC ≤ 2 cm.LND can provide more accurate pathological stage, may affect survival, and should be recommended for above patients.

29 June 2021 in Research Square
Verified
Preprint
Open access
PDF file
WZWeigang Zhao
Weigang Zhao
SZShu Zhu
Shu Zhu
ZSZuodong Song
Zuodong Song
Background: Isolated malignant pulmonary nodules were frequently seen in patients with breast cancer. These were metastasis from the breast cancer or new primary lung cancer. The role of surgery for such pulmonary nodules remains unclear.Methods: A total of 90 patients who underwent surgery for solitary malignant pulmonary nodules between January 2010 and April 2018 after curative operation for breast cancer were reviewed.Results: The pathologic diagnoses revealed 63 patients with primary lung cancer (PLC) and 27 patients with pulmonary metastatic breast cancer (MBC), which were divided into two groups. All patients were female with a mean age of 55.08±9.84 years (range 31-75). Age differences between the two groups were insignificant. Of the 63 patients with PLC, 55(87%) had a lobectomy with lymphadenctomy and 8(13%) had a limited resection, while the majority of patients (78%) with MBC had a limited resection. All nodules were adenocarcinomas and their mean diameter was 1.63±0.57cm. 7/55 of patients with PLC had N1 disease while 3/6 of those with MBC had involvement of N1 nodes. For all patients, the overall survival (OS) was 86.1% at 5 years and the disease free survival (DFS) was 86.0% at 5 years. Patients with PLC had the better surgical outcomes including OS and DFS than those with MBC did (94.2% versus 72.8%, p=0.017; 93.6% versus 63.9%, p=0.002).Conclusions: Surgical outcomes of isolated malignant pulmonary nodules in breast cancer patients were favorable. Surgery should be considered as an option for breast cancer patients with isolated pulmonary nodules.

31 August 2020 in Research Square
Verified
Preprint
Open access
PDF file
WZWeigang Zhao
Weigang Zhao
YCYonglin Chen
Yonglin Chen
WHWeiwei He
Weiwei He
YZYonghong Zhao
Yonghong Zhao
YYYi Yang
Yi Yang
Background: Nonintubated video-assisted thoracoscopic surgery has been widely reported in the past decade, while nonintubated chest wall stabilization has not been reported previously. The aim of this study was to evaluate the safety and feasibility of nonintubated minimally invasive chest wall stabilization in patients with multiple rib fractures.Methods: We conducted a prospective, single-arm, observational study. In this prospective study, 20 consecutive patients with multiple rib fractures were treated using nonintubated minimally invasive chest wall stabilization.Results: Minimally invasive chest wall stabilization was mostly performed for lateral rib fractures in this study (n=8). The mean operation time was 92.5 minutes, and the mean blood loss was 49 ml. No patient required conversion to tracheal intubation. The mean extubation time of the laryngeal mask was 8.9 minutes; the mean postoperative fasting time was 6.1 hours; the mean postoperative hospital stay was 6.2 days; the mean amount of postoperative drainage was 97.5 ml; the mean postoperative pain score was 2.9 points at 6 hours, 2.8 points at 12 hours, and 3.0 points at 24 hours; and the mean postoperative nausea and vomiting score was 1.9 points at 6 hours, 1.8 points at 12 hours, and 1.7 points at 24 hours.Conclusions: Nonintubated minimally invasive chest wall stabilization is safe and feasible in carefully selected patients. Further studies with a large sample size are warranted.